China Risun Group (1907) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
30 Mar, 2026Executive summary
Maintained global leadership in coke production and significant positions in refined chemicals and hydrogen-energy sectors, with nine production bases and expanded operation management services to eight third-party producers.
Completed major capacity expansions, including new coke and refined chemicals projects, and launched China's first national liquid hydrogen project.
Implemented ESG initiatives, digitalization, and R&D advancements, earning multiple green and intelligent factory recognitions.
Granted 14.4 million share awards to nearly 800 employees to enhance competitiveness and retention.
Financial highlights
Revenue decreased 17.4% year-over-year to RMB39,286.5 million, mainly due to lower product prices and weaker demand.
Net profit increased 37.7% year-over-year to RMB134.7 million, driven by cost control, efficiency improvements, and non-recurring gains.
Gross profit margin rose to 7.8% from 7.3% last year; EBITDA margin improved to 9.2%.
Basic EPS rose 160% year-over-year to RMB1.3 cents.
Final dividend proposed at RMB0.19 cents per share, totaling RMB8.13 million.
Net cash from operating activities increased to RMB3,464.9 million; cash and cash equivalents at year-end were RMB1,578.8 million.
Total borrowings increased 13.2% to RMB34.4 billion, with gearing ratio at 2.3.
Outlook and guidance
New five-year plan (2026–2030) targets further expansion in coke, refined chemicals, and hydrogen-energy, leveraging M&A and joint ventures.
Focus on technological innovation, green development, and digital transformation to drive growth and maintain industry leadership.
Hydrogen-energy business expected to benefit from supportive national policies and industry commercialization.
Latest events from China Risun Group
- Revenue and profit fell despite higher production; focus shifts to innovation and hydrogen energy.1907
H1 202525 Sep 2025 - Revenue up 21% but net profit down 84% as margins tighten and leverage rises.1907
H1 202412 Sep 2025 - Revenue up, profit down sharply; refined chemicals and management segments drive growth.1907
H2 202411 Sep 2025